A rare SARS-CoV-2 complication: Candida spondylodiscitis following SARS-CoV-2 infection-two case reports

被引:0
作者
Gaviraghi, Alberto [1 ,5 ]
Vita, Davide [1 ]
Stroffolini, Giacomo [2 ]
Lupia, Tommaso [3 ]
Boglione, Lucio [4 ]
机构
[1] Univ Turin, Dept Med Sci, Unit Infect Dis, Turin, Italy
[2] IRCCS Sacro Cuore Don Calabria Hosp, Dept Infect Trop Dis & Microbiol, Verona, Italy
[3] Cardinal Massaia Hosp, Unit Infect Dis, Asti, Italy
[4] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy
[5] Univ Turin, Dept Med Sci, Unit Infect Dis, Via Verdi 8, I-10124 Turin, TO, Italy
关键词
Coronavirus disease 2019 (COVID-19); candidiasis; spondylodiscitis; case report; CLINICAL-PRACTICE GUIDELINES; VERTEBRAL OSTEOMYELITIS; DISEASES SOCIETY; MANAGEMENT; DIAGNOSIS;
D O I
10.21037/jphe-22-71
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: In the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, opportunistic fungal co-/super-infections have surged globally. This report focuses on Candida spondylodiscitis (CS), an uncommon complication of severe SARS-CoV-2 infection without classical risk factors for invasive candidiasis. Case Description: The first case involved a Hispanic 65-year-old man with severe SARS-CoV-2 infection, developing low-back pain. Magnetic resonance imaging (MRI) and biopsy revealed Candida albicans L4-L5 spondylodiscitis. Initial treatment with fluconazole showed limited improvement; subsequently, liposomal amphotericin and increased fluconazole were administered. Despite treatment adjustments, clinical response was delayed. After a switch to itraconazole, the patient experienced a 17-month antifungal regimen, leading to clinical and radiological improvement. The second case featured an 86-year-old Caucasian man with a history of chronic obstructive pulmonary disease, hypertension, chronic kidney disease, and a recent positive blood culture for Candida tropicalis during severe SARS-CoV-2 infection. An MRI confirmed spondylodiscitis at L3-L4 and L4-L5, and left psoas muscle involvement. Treatment included fluconazole, later interrupted due to worsened liver function tests. Following a regimen with liposomal amphotericin B and fluconazole, the patient exhibited clinical improvement, supported by a positron emission tomographycomputed tomography (PET-CT) showing regression of spondylodiscitis. Conclusions: These cases, unlike previous literature, involved intensive care unit-admitted SARS-CoV-2 patients, emphasizing the need for tailored coronavirus disease 2019 (COVID-19) management. Literature review indicated limited reports of CS in COVID-19 patients. In conclusion, severe SARS-CoV-2 infection creates a conducive environment for fungal proliferation, especially in critically ill patients subjected to various predisposing factors. Fungal aetiology should be considered in spondylodiscitis cases in this patient group.
引用
收藏
页数:10
相关论文
共 32 条
[1]   COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions? [J].
Arastehfar, Amir ;
Carvalho, Agostinho ;
Nguyen, M. Hong ;
Hedayati, Mohammad Taghi ;
Netea, Mihai G. ;
Perlin, David S. ;
Hoenigl, Martin .
JOURNAL OF FUNGI, 2020, 6 (04) :1-13
[2]   Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia [J].
Azoulay, E ;
Timsit, JF ;
Tafflet, M ;
de Lassence, A ;
Darmon, M ;
Zahar, JR ;
Adrie, C ;
Garrouste-Orgeas, M ;
Cohen, Y ;
Mourvillier, B ;
Schlemmer, B .
CHEST, 2006, 129 (01) :110-117
[3]   Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients [J].
Basile, Kerri ;
Halliday, Catriona ;
Kok, Jen ;
Chen, Sharon C-A. .
JOURNAL OF FUNGI, 2022, 8 (01)
[4]   Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients [J].
Bellmann, Romuald ;
Smuszkiewicz, Piotr .
INFECTION, 2017, 45 (06) :737-779
[5]   Executive Summary: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa [J].
Berbari, Elie F. ;
Kanj, Souha S. ;
Kowalski, Todd J. ;
Darouiche, Rabih O. ;
Widmer, Andreas F. ;
Schmitt, Steven K. ;
Hendershot, Edward F. ;
Holtom, Paul D. ;
Huddleston, Paul M. ;
Petermann, Gregory W. ;
Osmon, Douglas R. .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) :859-863
[6]  
Broner FA, 1996, ORTHOP CLIN N AM, V27, P37
[7]   Invasive Fungal Infections Complicating COVID-19: A Narrative Review [J].
Casalini, Giacomo ;
Giacomelli, Andrea ;
Ridolfo, Annalisa ;
Gervasoni, Cristina ;
Antinori, Spinello .
JOURNAL OF FUNGI, 2021, 7 (11)
[8]   Candida albicans lumbar spondylodiscitis in an intravenous drug user: A case report [J].
Chen C.-H. ;
Chen W.L. ;
Yen H.-C. .
BMC Research Notes, 6 (1)
[9]   ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients [J].
Cornely, O. A. ;
Bassetti, M. ;
Calandra, T. ;
Garbino, J. ;
Kullberg, B. J. ;
Lortholary, O. ;
Meersseman, W. ;
Akova, M. ;
Arendrup, M. C. ;
Arikan-Akdagli, S. ;
Bille, J. ;
Castagnola, E. ;
Cuenca-Estrella, M. ;
Donnelly, J. P. ;
Groll, A. H. ;
Herbrecht, R. ;
Hope, W. W. ;
Jensen, H. E. ;
Lass-Floerl, C. ;
Petrikkos, G. ;
Richardson, M. D. ;
Roilides, E. ;
Verweij, P. E. ;
Viscoli, C. ;
Ullmann, A. J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 :19-37
[10]   Candidemia in the Intensive Care Unit [J].
Epelbaum, Oleg ;
Chasan, Rachel .
CLINICS IN CHEST MEDICINE, 2017, 38 (03) :493-+